Esophageal squamous cell carcinoma (ESCC) is one of the most common human
malignancies worldwide and is associated with high morbidity and mortality. More than 70 …

With cancer being a leading cause of death globally, there is an urgent need to improve
therapeutic strategies and identify effective chemotherapeutics. This study aims to highlight …

The programmed cell death 1 protein (PD-1)/programmed cell death ligand 1 (PD-L1) axis
plays a crucial role in tumor immunosuppression, while the cancer-associated fibroblasts …

Esophageal squamous cell carcinoma (ESCC) remains a major health challenge, with
cisplatin (CDDP) being the primary chemotherapy drug, albeit accompanied by resistance …

Increasing studies indicate that circular RNAs (circRNAs) play critical roles in tumor
metabolism of multiple cancers. However, the contribution of circRNAs in glutamine …

Background Prediction of prognosis for patients with esophageal cancer (EC) is beneficial
for their postoperative clinical decision-making. This study's goal was to create a …

Esophageal squamous cell carcinoma (ESCC) is an aggressive malignant tumor with a poor
prognosis due to insidious symptoms that make early diagnosis difficult. Despite the …

Simple Summary Esophageal squamous cell carcinoma (SCC) is an extremely aggressive
malignancy with high mortality rates. An important variable in understanding this …

Background Esophageal cancer is one of the most unknown and deadliest cancers in the
world. Although recent studies have identified some mutations linked to the development of …

Lacking effective therapeutic targets heavily restricts the improvement of clinical prognosis
for patients diagnosed with esophageal squamous cell carcinoma (ESCC). Ubiquitin …